BTIG Maintains Buy on CareDx, Raises Price Target to $60

Benzinga Newsdesk www.benzinga.com Positive 65.3%

Neg 0% Neu 0% Pos 65.3%

BTIG analyst Mark Massaro maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $45 to $60.

Comments

No comments yet. Be the first!